Using cutting-edge genetic coding to kill diseased cells, Israeli researchers may have discovered the first “complete cure for cancer.”
By United with Israel Staff
A treatment pioneered by a team of Israeli scientists may represent the first “complete cure for cancer,” according to Dan Aridor, chairman of the board of the company developing the treatment, Israel’s Accelerated Evolution Biotechnologies Ltd. (AEBi).
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor told the Jerusalem Post.
The treatment is called MuTaTo (multi-target toxin) and was analogized to a “cancer antibiotic” in a report in the Post. The team developed the cancer therapy after assessing a variety of cancer drugs and treatments that failed in the past.
MuTaTo uses a combination of several amino acids to specifically target and kill cancer cells.
AEBi CEO Dr. Ilan Morad explained to the Post, “We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”